猴腺病毒GD株的分离与鉴定

目的 体外分离出猴腺病毒(simian adenovirus,SAdV)毒株,并对其进行鉴定,为SAdV的生物学特性、致病机制和诊断试剂等方面的研究提供基础.方法 采用PCR法对猕猴粪便样本进行SAdV筛查,将PCR检测为阳性的样本处理后接种BSC-1细胞,盲传3代后用PCR扩增测序并负染色电镜观察.结果 从广东地区食蟹猴粪便样本中成功分离出一株SAdV,细胞病变明显,PCR检测呈阳性,电镜下可观察到典型腺病毒样形态的病毒粒子,命名为GD株.经测序鉴定,发现GD株属HAdV-G亚属,与SAdV-1进化发生距离最近.结论 GD株的分离成功,使猴腺病毒基因转移载体的构建成为可能,有助于猴腺病毒替代载体的发展.     

人腺病毒流行病学研究进展

人腺病毒(Human adenovirus,HAdV)是引起儿童急性呼吸道感染(ARTIs)的主要原因之一,可引起重症肺炎的暴发流行,迄今为止尚无安全有效的防治手段.HAdV已有52个血清型,被分为7组,即HAdV A-G.有研究提示不同的型别导致的疾病严重程度不同,不同时间和地区的优势型别也有所差异.近年来,不断有新的HAdV型别被发现,已报道的共有103个型别.HAdV不断地以重组等方式进化,导致了组织嗜性和中和特性的改变,从而产生高致病性、高传染性的新型毒株,对疾病防控提出了新的挑战.本文以已有研究结果为基础,综合对HAdV的流行病学特征进行综述,为HAdV的疫苗研制和疾病防控提供参考依据.     

人腺病毒的研究进展

人腺病毒(Human adenovirus,HAdV)是引起婴幼儿急性呼吸道感染等多种疾病的重要病原体之一,本文回顾了有关HAdV的分子生物学特征、检测方法及分型、致病机制、相关疾病的临床特征、流行病学特征、HAdV感染的预防和控制研究的文献。迄今为止明确的HAdV有67种不同型别,包括近几年发现的重组变异株。导致急性呼吸道感染的主要流行株为HAdV-3和HAdV-7,属于B亚组,也可以引起其他系统的疾病,所致疾病的临床表现与其他呼吸道病毒相关病毒相似,但多伴消化道症状,其致病机制尚不清楚。对于新发现的变异重组株,其与疾病的相关性研究甚少,需要进一步研究证实。由于没有前瞻性的、大样本的随机对照治疗试验,HAdV感染的治疗目前存在争议。疫苗是降低呼吸道HAdV感染最有效的措施,但还没有上市的产品。     

猴痘病毒的分类、演化和宿主范围:痘病毒的系统综述和分析（英文）

近20年来,偶发的感染人类的猴痘疾病严重影响了公共卫生和经济。啮齿类动物是猴痘病毒（MPXV）在自然界的主要宿主。MPXV可以通过直接接触传播至人并引起自限性感染,出现皮疹和淋巴结症状。本世纪初,美国报道了第一例在非洲以外地区人感染MPXV的病例,此后,猴痘逐步在全世界流行,并成为严重的公共威胁。随着病毒检测和测序技术的发展,许多新的痘病毒被发现,从而丰富了痘病毒科的多样性。本综述对MPXV以及痘病毒科中的其他病毒的最新分类、宿主范围、基因组结构特点、致病性以及遗传进化关系进行了全面概述。这些信息将促进我们对痘病毒的遗传进化关系和传播的了解,并且对未来病毒的研究和疾病的控制提供帮助。     

腺病毒载体在基因治疗和疫苗研究中的应用

自从二十世纪五十年代开始认识腺病毒（Adenovirus）以来,对腺病毒的生物学和免疫学特征已经有比较多的认识。腺病毒科包括禽腺病毒属（Aviadenovius）和哺乳动物腺病毒（Mastadenov irus）两个属。除人腺病毒以外,一些哺乳动物的腺病毒和禽腺病毒也成为基因治疗和载体疫苗研究的热点,如猪腺病毒3型（PAV-3）、牛腺病毒3型（BAV-3）、绵羊腺病毒（Ovine adenovirus,OAV）、禽腺病毒（Aviadenovirus）、犬腺病毒（Canine adeno virus,CAV）和黑猩猩腺病毒（Chimpanzee adenovirus）。不同种属的腺病毒虽然基因组序列完全不同,但其结构和功能却非常相似,而且各型腺病毒之间很少有交叉免疫反应,这就为利用这些腺病毒研制基因治疗载体和活载体疫苗提供了丰富的材料。近年来的研究也发现,如果利用一种腺病毒载体来进行重复免疫,宿主针对腺病毒载体蛋白的免疫反应比较强大,造成转基因表达时间缩短,重复免疫的效果较差,换用不同的病毒载体,则可以回避这种免疫反应,提高转基因的表达时间和保护性免疫反应。腺病毒可以感染很多分裂期或静止期细胞,即使在一些高度分化的组织细胞中也可增殖,如可有效的感染肌肉组织、心、肺和脑组织,并能高效的复制、表达其基因产物,因此腺病毒成为基因治疗和活病毒载体疫苗研究的首选工具。     

虎血清犬腺病毒抗体调查

犬腺病毒（Canine adenovirus,CAV）属于腺病毒科哺乳动物腺病毒属成员,分为犬腺病毒Ⅰ型（CAV-1）和犬腺病毒Ⅱ型（CAV-2）,其中CAV-1主要引起狐狸（Vulpes vulpes）脑炎和犬（Canis familiaris）传染性肝炎（殷震和刘景华,1997;胡体拉,1963）。在国内,夏咸柱等（1984）首次分离到CAV-1,随后,多个地区的不同动物中又有相继分离到该病毒的报道（钟志宏等,1990;范泉水和袁国庆,1992;夏咸柱等,1984）。CAV-2主要引起犬的喉气管炎和幼犬咳嗽,在我国的感染也比较普遍（范泉水和夏咸柱,1999）。     

猴腺病毒（SAdV）PCR检测方法的建立及初步应用

目的建立SAdV特异的PCR检测方法并研究实验猴群和猴源性生物制品中SAdV感染或污染情况。方法比对分析多株SAdV序列,设计SAdV特异引物,优化PCR实验条件,建立的PCR方法经验证后检测实验猴群和猴源性生物制品,阳性产物测序并构建进化树。结果经特异性和敏感性鉴定,在设计的5对引物中确定一对最佳引物,可以区分SAdV和MAD,ICH,CELO且可以检测到的最小DNA量为47.9 pg/mL。PCR方法检测实验猴群,阳性率49.2%,测序及进化分析表明,SAdV感染型别呈广泛基因多样性。主要分布在G亚属和以SAdV-49为代表的分支。结论经测序验证,PCR检测方法具有很好准确性,初步应用表明我国实验猴群中SAdV高度流行,应加强实验猴群及相关生物制品中SAdV的监测,避免人类感染SAdV的潜在风险。     

北京地区两株人偏肺病毒M蛋白基因的原核表达及抗原活性分析

人偏肺病毒(Human metapneumovirus,hMPV)是最近发现的可引起人类呼吸道感染的一种副粘病毒,现被归类于偏肺病毒属(Metapneumovirus),是至今发现的第一个与人类疾病相关的偏肺病毒属成员[1]。目前已经受到世界范围的重视,已有十多个国家报道了不同年龄组人群中hMPV的感染情况。     

关于新型冠状病毒动物宿主和动物感染的研究进展

新型冠状病毒（Severe acute respiratory syndrome coronavirus 2, SARS-CoV-2）是一种全新的病毒,是继严重急性呼吸综合征冠状病毒（Severe acute respiratory syndrome coronavirus, SARS-CoV）和中东呼吸综合征冠状病毒（Middle East Respiratory Syndrome Syndrome Coronavirus, MERS-CoV）之后引起人类大范围感染的第三种冠状病毒。目前不少研究提示SARS-CoV-2可能来源于动物,动物在疫情的发生与传播过程中起着重要作用。这篇综述总结了目前关于SARS-CoV-2动物宿主和动物易感性的最新研究进展。现有研究提示,SARS-CoV-2很可能起源于蝙蝠,穿山甲是中间宿主。恒河猴,水貂、白尾鹿,动物园里的老虎、狮子,以及宠物猫、狗等动物可能在暴露后发生SARS-CoV-2感染,此外实验室动物感染实验也证明了一些动物对SARS-CoV-2易感,提示下一步需要加强对动物宿主中的SARS-CoV-2监测,为病毒溯源、变异进化规律与传播机制分析...     

我国猕猴体内奇生虫调查报告

猿猴类生活于热带,亚热带森林地区,行群居生活,因此容易感染各种寄生虫病[Wardle,1952;Ruch,1959]而且猴群亦有进入人类生活圈的机会,许多寄生虫病是人猴共有的。研究猿猴寄生虫对防治猴病,保障猴群健康有重要作用[naliHH,1963;Kaufmann,1971],同时,应用猴子作为人类寄生虫的实验模型[Valcrio,1971;Pryor,1970],亦极有意义。最早应用猿猴作为实验动物,就是应用猴子作实验性疟疾的研究。近年来,应用幼年猴进行疟疾的实验治疗和免疫学的研究,屡见报道。而且其它人体寄生虫应用猴子作试验的也並不少见。关于我国所产猕猴猴体寄生虫的调查[尹文直 1973]材料不多,尚未见有完整的报告。为了能充分利用猴子这一宝贵的实验动物,进行寄生虫学的研究,我们将1960年到1979年中,从野外捕捉的十一批猕猴所进行的猴体寄生虫调查,报告如下:     

Genomics-based re-examination of the taxonomy and phylogeny of human and simian Mastadenoviruses: an evolving whole genomes approach,revealing putative zoonosis,anthroponosis, and amphizoonosis

With the advent of high-resolution and cost-effective genomics and bioinformatics tools and methods contributing to a large database of both human (HAdV) and simian (SAdV) adenoviruses, a genomics-based re-evaluation of their taxonomy is warranted. Interest in these particular adenoviruses is growing in part due to the applications of both in gene transfer protocols, including gene therapy and vaccines, as well in oncolytic protocols. In particular, the re-evaluation of SAdVs as appropriate vectors in humans is important as zoonosis precludes the assumption that human immune system may be naïve to these vectors. Additionally, as important pathogens, adenoviruses are a model organism system for understanding viral pathogen emergence through zoonosis and anthroponosis, particularly among the primate species, along with recombination, host adaptation, and selection, as evidenced by one long-standing human respiratory pathogen HAdV-4 and a recent re-evaluation of another, HAdV-76. The latter reflects the insights on amphizoonosis, defined as infections in both directions among host species including “other than human”, that are possible with the growing database of nonhuman adenovirus genomes. HAdV-76 is a recombinant that has been isolated from human, chimpanzee, and bonobo hosts. On-going and potential impacts of adenoviruses on public health and translational medicine drive this evaluation of 174 whole genome sequences from HAdVs and SAdVs archived in GenBank. The conclusion is that rather than separate HAdV and SAdV phylogenetic lineages, a single, intertwined tree is observed with all HAdVs and SAdVs forming mixed clades. Therefore, a single designation of “primate adenovirus” (PrAdV) superseding either HAdV and SAdV is proposed, or alternatively, keeping HAdV for human adenovirus but expanding the SAdV nomenclature officially to include host species identification as in ChAdV for chimpanzee adenovirus, GoAdV for gorilla adenovirus, BoAdV for bonobo adenovirus, and ad libitum.     

Isolation and Characterization of Adenoviruses Persistently Shed from the Gastrointestinal Tract of Non-Human Primates

Adenoviruses are important human pathogens that have been developed as vectors for gene therapies and genetic vaccines. Previous studies indicated that human infections with adenoviruses are self-limiting in immunocompetent hosts with evidence of some persistence in adenoid tissue. We sought to better understand the natural history of adenovirus infections in various non-human primates and discovered that healthy populations of great apes (chimpanzees, bonobos, gorillas, and orangutans) and macaques shed substantial quantities of infectious adenoviruses in stool. Shedding in stools from asymptomatic humans was found to be much less frequent, comparable to frequencies reported before. We purified and fully sequenced 30 novel adenoviruses from apes and 3 novel adenoviruses from macaques. Analyses of the new ape adenovirus sequences (as well as the 4 chimpanzee adenovirus sequences we have previously reported) together with 22 complete adenovirus genomes available from GenBank revealed that (a) the ape adenoviruses could clearly be classified into species corresponding to human adenovirus species B, C, and E, (b) there was evidence for intraspecies recombination between adenoviruses, and (c) the high degree of phylogenetic relatedness of adenoviruses across their various primate hosts provided evidence for cross species transmission events to have occurred in the natural history of B and E viruses. The high degree of asymptomatic shedding of live adenovirus in non-human primates and evidence for zoonotic transmissions warrants caution for primate handling and housing. Furthermore, the presence of persistent and/or latent adenovirus infections in the gut should be considered in the design and interpretation of human and non-human primate studies with adenovirus vectors.     

Marburg and Ebola virus infections in laboratory non-human primates: a literature review

BACKGROUND AND PURPOSE: Several non-human primate species are used as laboratory animals for various types of studies. Although importation of monkeys may introduce different diseases, special attention has recently been drawn to Marburg and Ebola viruses. This review presented here discusses the potential risk of these viruses for persons working with non-human primates as laboratory animals by focusing on epidemiology, virology, symptoms, pathogenesis, natural reservoir, transmission, quarantine of non-human primates, therapy, and prevention. CONCLUSION: A total of 23 Marburg and Ebola virus outbreaks causing viral hemorrhagic fever has been reported among humans and monkeys since the first outbreak in Marburg, Germany in 1967. Most of the 1,100 human cases, with nearly 800 deaths, developed in Africa due mainly to direct and intimate contact with infected patients. Few human cases have developed after contact with non-human primates used for various scientific purposes. However, adequate quarantine should be applied to prevent human infections not only due to Marburg and Ebola viruses, but also to other infective agents. By following proper guidelines, the filovirus infection risk for people working with non-human primates during quarantine exists, but is minimal. There seems to be little risk for filovirus infections after an adequate quarantine period. Therefore, non-human primates can be used as laboratory animals, with little risk of filovirus infections, provided adequate precautions are taken.     

Phylogenetic Evidence That Two Distinct Trichuris Genotypes Infect both Humans and Non-Human Primates

Although there has been extensive debate about whether Trichuris suis and Trichuris trichiura are separate species, only one species of the whipworm T. trichiura has been considered to infect humans and non-human primates. In order to investigate potential cross infection of Trichuris sp. between baboons and humans in the Cape Peninsula, South Africa, we sequenced the ITS1-5.8S-ITS2 region of adult Trichuris sp. worms isolated from five baboons from three different troops, namely the Cape Peninsula troop, Groot Olifantsbos troop and Da Gama Park troop. This region was also sequenced from T. trichiura isolated from a human patient from central Africa (Cameroon) for comparison. By combining this dataset with Genbank records for Trichuris isolated from other humans, non-human primates and pigs from several different countries in Europe, Asia, and Africa, we confirmed the identification of two distinct Trichuris genotypes that infect primates. Trichuris sp. isolated from the Peninsula baboons fell into two distinct clades that were found to also infect human patients from Cameroon, Uganda and Jamaica (named the CP-GOB clade) and China, Thailand, the Czech Republic, and Uganda (named the DG clade), respectively. The divergence of these Trichuris clades is ancient and precedes the diversification of T. suis which clustered closely to the CP-GOB clade. The identification of two distinct Trichuris genotypes infecting both humans and non-human primates is important for the ongoing treatment of Trichuris which is estimated to infect 600 million people worldwide. Currently baboons in the Cape Peninsula, which visit urban areas, provide a constant risk of infection to local communities. A reduction in spatial overlap between humans and baboons is thus an important measure to reduce both cross-transmission and zoonoses of helminthes in Southern Africa.     

Failure to detect simian immunodeficiency virus infection in a large Cameroonian cohort with high non-human primate exposure

Hunting and butchering of wildlife in Central Africa are known risk factors for a variety of human diseases, including HIV/AIDS. Due to the high incidence of human exposure to body fluids of non-human primates, the significant prevalence of simian immunodeficiency virus (SIV) in non-human primates, and hunting/butchering associated cross-species transmission of other retroviruses in Central Africa, it is possible that SIV is actively transmitted to humans from primate species other than mangabeys, chimpanzees, and/or gorillas. We evaluated SIV transmission to humans by screening 2,436 individuals that hunt and butcher non-human primates, a population in which simian foamy virus and simian T-lymphotropic virus were previously detected. We identified 23 individuals with high seroreactivity to SIV. Nucleic acid sequences of SIV genes could not be detected, suggesting that SIV infection in humans could occur at a lower frequency than infections with other retroviruses, including simian foamy virus and simian T-lymphotropic virus. Additional studies on human populations at risk for non-human primate zoonosis are necessary to determine whether these results are due to viral/host characteristics or are indicative of low SIV prevalence in primate species consumed as bushmeat as compared to other retroviruses in Cameroon.     

Epidemiological study of zoonoses derived from humans in captive chimpanzees

Emerging infectious diseases (EIDs) in wildlife are major threats both to human health and to biodiversity conservation. An estimated 71.8 % of zoonotic EID events are caused by pathogens in wildlife and the incidence of such diseases is increasing significantly in humans. In addition, human diseases are starting to infect wildlife, especially non-human primates. The chimpanzee is an endangered species that is threatened by human activity such as deforestation, poaching, and human disease transmission. Recently, several respiratory disease outbreaks that are suspected of having been transmitted by humans have been reported in wild chimpanzees. Therefore, we need to study zoonotic pathogens that can threaten captive chimpanzees in primate research institutes. Serological surveillance is one of several methods used to reveal infection history. We examined serum from 14 captive chimpanzees in Japanese primate research institutes for antibodies against 62 human pathogens and 1 chimpanzee-borne infectious disease. Antibodies tested positive against 29 pathogens at high or low prevalence in the chimpanzees. These results suggest that the proportions of human-borne infections may reflect the chimpanzee’s history, management system in the institute, or regional epidemics. Furthermore, captive chimpanzees are highly susceptible to human pathogens, and their induced antibodies reveal not only their history of infection, but also the possibility of protection against human pathogens.     

Zoonotic schistosomiasis in non-human primates: past, present and future activities at the human-wildlife interface in Africa

Schistosomiasis is one of the world's most widely distributed and prevalent parasitic diseases. Less widely recognized is that some species of Schistosoma, including several that commonly affect humans, also cause disease in other mammalian species; in particular, infections in non-human primates are known. With interest increasing in emerging zoonotic diseases, the status of schistosomiasis as a zoonotic infection is in need of re-appraisal, especially in light of advances in application of molecular screening and epidemiological tools where newly reported infections raise general animal welfare and conservation concerns. Focusing on Africa, this review provides a summary of the occurrence of schistosomiasis in non-human primates and discusses new ways in which surveillance for schistosomiasis should be integrated into more effective conservation management and disease control strategies. Emphasis is on the more common forms of human schistosomiasis, their clinical manifestations and epidemiological significance in terms of infection reservoir potential.     

Human is a unique species among primates in terms of telomere length.

TRF (terminal restriction fragments) length in various tissues of non-human primates such as Macaca mulatta (rhesus monkey), Macaca fuscata (Japanese monkey), Macaca fascicularis (crab-eating monkey), Pan troglodytes (common chimpanzee), and Pongo pygmaeus (orangutan) was at least 23 kb without exception, which was quite different from that of human somatic tissues (smaller than 10 kb). The distribution pattern of telomerase activity among tissues was similar between human and non-human primates, while the activity level showed some differences such as that strong telomerase activity was observed in gastrointestinal and lymphocytic tissues from non-human primates. The human appears to be a unique species among primates in terms of telomere length.